RXRX News and Press, Recursion Pharmaceuticals Inc. From 06/14/24

2024-06-14 13:28:07 ET Summary Recursion Pharma is an AI-driven drug developer that boasts supercomputers designed to shorten drug development timelines and enhance successful outcomes. Many such companies have raised substantial sums from private equity and hedge funds but few ha...

2024-06-07 09:00:00 ET Investing in growth stocks can lead to significant returns for investors in the long run. But oftentimes, the best returns come from smaller stocks, which have modest market values. These stocks can be risky options, but due to their low valuations, they tend to have ...

2024-06-07 07:00:00 ET More on Nvidia and the markets Cathie Wood says ARKK is well positioned for AI even though it cut NVDA positions Nvidia at $3T: ETFs with the biggest weightings in the hot AI chipmaker AI “mini bubbles” will emerge as the world ad...

2024-06-06 09:08:00 ET Summary We recently rebalanced the WisdomTree Artificial Intelligence & Innovation Index, which is tracked by the WisdomTree Artificial Intelligence & Innovation Fund. The top 10 holdings in WTAI reflect the importance of big platform companies and t...

2024-06-03 06:15:00 ET Everyone wants a piece of the fast-growing and highly promising artificial intelligence (AI) market. Various famous names on Wall Street have somewhat different picks in the field, although the same few select corporations seem to get most of the attention. Perhaps th...

2024-06-02 03:40:00 ET Making a million dollars on a stock investment is one of those classic goals you hear many investors say they dream about. And in some rare cases, the dream of a massive return that generates life-changing profits does come true. Investors who took a chance on high-fl...

SALT LAKE CITY, May 29, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today published in Nature Genetics scientific findings that highlights a potential limitation of CRISPR-Cas9 in gene editing - ...

2024-05-27 09:40:00 ET Summary Google DeepMind and Isomorphic Labs have recently unveiled an exciting new breakthrough, AlphaFold 3. AlphaFold 3 employs advanced AI algorithms to accurately model molecular structures and interactions. Beyond drug discovery, AlphaFold 3’...

SALT LAKE CITY, May 24, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that Robert Hershberg, M.D., Ph.D, has been appointed the new Chair of the Board of Recursion, effective at the end...

2024-05-24 06:30:00 ET Things aren't so bad for investors right now. We are in a bull market even though the economy is still having some problems. However, this bull run won't last forever. There will be a slowdown, equities will fall, and many won't deliver anything approaching decent ret...